$3.16 Billion is the total value of BRAIDWELL LP's 86 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 59.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $108,902,700 | +23.7% | 968,024 | +3.7% | 3.44% | +19.7% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $71,852,007 | +2.1% | 2,103,396 | +15.0% | 2.27% | -1.3% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $61,504,080 | +58.6% | 1,164,850 | +62.5% | 1.94% | +53.4% |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $59,080,314 | +53.8% | 879,564 | +58.1% | 1.87% | +48.8% |
| Buy | NUVASIVE INCnote 0.375% 3/1 | $56,647,490 | +13.1% | 61,340,000 | +10.9% | 1.79% | +9.4% | |
| New | INSULET CORPnote 0.375% 9/0 | $53,573,500 | – | 54,500,000 | +100.0% | 1.69% | – | |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $53,554,479 | +7.3% | 568,157 | +18.7% | 1.69% | +3.7% |
| Buy | BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $50,470,500 | +30.9% | 67,294,000 | +8.0% | 1.60% | +26.6% | |
| New | SAREPTA THERAPEUTICS INCnote 1.250% 9/1 | $49,549,835 | – | 44,166,000 | +100.0% | 1.57% | – | |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $47,071,899 | +67.7% | 906,973 | +93.8% | 1.49% | +62.3% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $45,590,081 | +13.6% | 3,715,573 | +10.5% | 1.44% | +9.8% |
| Buy | NEOGENOMICS INCnote 0.250% 1/1 | $45,191,662 | +25.2% | 62,601,000 | +28.6% | 1.43% | +21.1% | |
| KROS | Buy | KEROS THERAPEUTICS INC | $43,271,011 | -5.9% | 1,357,309 | +18.7% | 1.37% | -9.0% |
| Buy | PARAGON 28 INC | $42,190,891 | +11.3% | 3,361,824 | +57.4% | 1.33% | +7.7% | |
| MRVI | Buy | MARAVAI LIFESCIENCES HLDGS I | $39,748,570 | +77.2% | 3,974,857 | +120.3% | 1.26% | +71.4% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $38,341,871 | +169.2% | 75,749 | +177.5% | 1.21% | +160.6% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $37,969,898 | +93.2% | 5,362,980 | +92.1% | 1.20% | +86.9% |
| New | IRONWOOD PHARMACEUTICALS INCnote 0.750% 6/1 | $37,250,188 | – | 37,509,000 | +100.0% | 1.18% | – | |
| New | DEXCOM INCnote 0.250%11/1 | $35,531,250 | – | 37,500,000 | +100.0% | 1.12% | – | |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $33,848,640 | +1.4% | 1,057,770 | +39.0% | 1.07% | -1.9% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $26,617,692 | -7.2% | 1,735,182 | +43.8% | 0.84% | -10.3% |
| OM | Buy | OUTSET MED INC | $26,116,646 | -18.2% | 2,400,427 | +64.4% | 0.82% | -21.0% |
| HROW | Buy | HARROW INC | $25,990,789 | -6.0% | 1,808,684 | +24.5% | 0.82% | -9.2% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $25,913,528 | – | 1,289,872 | +100.0% | 0.82% | – |
| ETNB | New | 89BIO INC | $24,555,575 | – | 1,590,387 | +100.0% | 0.78% | – |
| PEN | Buy | PENUMBRA INC | $23,057,652 | +1.8% | 95,315 | +44.8% | 0.73% | -1.5% |
| GH | Buy | GUARDANT HEALTH INC | $20,421,960 | +111.3% | 689,000 | +155.2% | 0.64% | +104.1% |
| LNTH | New | LANTHEUS HLDGS INC | $20,031,084 | – | 288,300 | +100.0% | 0.63% | – |
| Buy | CUTERA INCnote 2.250% 6/0 | $19,980,660 | +177.4% | 33,900,000 | +194.8% | 0.63% | +168.5% | |
| INSP | New | INSPIRE MED SYS INC | $19,903,532 | – | 100,300 | +100.0% | 0.63% | – |
| Buy | HILLEVAX INC | $19,492,359 | -9.2% | 1,449,246 | +16.0% | 0.62% | -12.3% | |
| Buy | MINERALYS THERAPEUTICS INC | $19,247,289 | +105.1% | 2,023,900 | +267.8% | 0.61% | +98.0% | |
| DHR | Buy | DANAHER CORPORATION | $19,153,320 | +44.1% | 77,200 | +39.4% | 0.60% | +39.4% |
| RGEN | Buy | REPLIGEN CORP | $18,826,784 | +44.7% | 118,400 | +28.7% | 0.60% | +40.0% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $18,500,622 | – | 1,109,150 | +100.0% | 0.58% | – |
| RAPT | Buy | RAPT THERAPEUTICS INC | $17,991,349 | -2.3% | 1,082,512 | +10.0% | 0.57% | -5.3% |
| INCY | New | INCYTE CORP | $17,036,373 | – | 294,900 | +100.0% | 0.54% | – |
| TMDX | New | TRANSMEDICS GROUP INC | $16,819,200 | – | 307,200 | +100.0% | 0.53% | – |
| DYN | Buy | DYNE THERAPEUTICS INC | $16,324,869 | +5.3% | 1,821,972 | +32.2% | 0.52% | +2.0% |
| New | IRONWOOD PHARMACEUTICALS INCnote 1.500% 6/1 | $15,141,950 | – | 15,500,000 | +100.0% | 0.48% | – | |
| TERN | Buy | TERNS PHARMACEUTICALS INC | $14,285,462 | -11.4% | 2,840,052 | +54.2% | 0.45% | -14.4% |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $12,982,193 | – | 1,348,099 | +100.0% | 0.41% | – |
| New | PROCEPT BIOROBOTICS CORP | $10,862,111 | – | 331,061 | +100.0% | 0.34% | – | |
| New | THIRD HARMONIC BIO INC | $10,569,002 | – | 1,653,991 | +100.0% | 0.33% | – | |
| New | APOGEE THERAPEUTICS INC | $10,460,707 | – | 491,113 | +100.0% | 0.33% | – | |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $9,789,941 | – | 1,626,236 | +100.0% | 0.31% | – |
| AMGN | New | AMGEN INC | $9,729,112 | – | 36,200 | +100.0% | 0.31% | – |
| AGEN | Buy | AGENUS INC | $7,126,944 | -5.2% | 6,307,030 | +34.3% | 0.22% | -8.5% |
| New | RAYZEBIO INC | $6,166,672 | – | 277,778 | +100.0% | 0.20% | – | |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $5,273,911 | +21.2% | 967,690 | +49.2% | 0.17% | +17.6% |
| MRUS | Buy | MERUS N V | $0 | -100.0% | 1,901,337 | +23.2% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GUARDANT HEALTH INC | 4 | Q3 2023 | 6.3% |
| EXACT SCIENCES CORP | 4 | Q3 2023 | 4.4% |
| NOVOCURE LTD | 4 | Q3 2023 | 3.9% |
| NANOSTRING TECHNOLOGIES INC | 4 | Q3 2023 | 4.0% |
| NEVRO CORP | 4 | Q3 2023 | 3.4% |
| BRIDGEBIO PHARMA INC | 4 | Q3 2023 | 3.5% |
| ALPHATEC HLDGS INC | 4 | Q3 2023 | 3.6% |
| GLAUKOS CORP | 4 | Q3 2023 | 3.0% |
| VAXCYTE INC | 4 | Q3 2023 | 2.8% |
| XENON PHARMACEUTICALS INC | 4 | Q3 2023 | 2.5% |
View BRAIDWELL LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.